Pediapharm Inc. (CVE:PDP – Get Free Report) was up 1.7% during trading on Friday . The company traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Trading Up 1.7 %
The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12. The company’s fifty day moving average is C$0.30 and its two-hundred day moving average is C$0.30. The company has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Featured Articles
- Five stocks we like better than Pediapharm
- Insider Trades May Not Tell You What You Think
- Realty Income: An Anchor in Volatile Markets
- Investing in Commodities: What Are They? How to Invest in Them
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Pros And Cons Of Monthly Dividend Stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
